FMO5 and chronic kidney disease: Impaired Nrf2 activity in the untreated CKD rats was associated with upregulation of NAD(P)H oxidase subunits p47phox, Gp91phox, and Rac-1, which is often observed in concert with the increase in expression of AT1.